Monoclonal Antibodies Look to a Bright Future

Monoclonal Antibodies Look to a Bright Future
Using mAbs as therapeutics could cut preclinical development time by as much as two-thirds and cost by even greater levels.

Click here for reuse options!
Copyright 2002 Biotechblog

Leave a Reply

%d bloggers like this: